Cordarone Cuts ICD Shocks, but Side Effects May Outweigh Benefit
11th Jan 2006, 16:37 GMT
HAMILTON, Ontario - Patients maintained on the antiarrhythmic Cordarone (amiodarone) after a defibrillator implant will have fewer shocks, but the drug's side-effects make it a difficult pill to swallow, researchers here reported.
Cordarone Cuts ICD Shocks, but Side Effects May Outweigh Benefit related news:
- Heart implant has no nasty shocks — BBC News | UK News | England | Cambridgeshire | World Edition
- GOING DOWN — Mirror.co.uk - News - Kevin Maguire
- Entity FX Nominated for Outstanding Visual Effects — PR Web - Breaking News Stories
- One Buffalo library reborn as community room — LISNews.org: Public Library News
- Medication plus beta-blocker helps prevent shocks from implantable cardioverter defibrillator — EurekAlert! - Medicine and Health
- Military aims to avoid cuts — NewsOk.com - Oklahoma
- Volume 637, number 1: LINER-like Extended Nebulae in ULIRGs: Shocks Generated by Merger-Induced Flows — ApJ Latest Issue
- NFIB joins tax cut push, critics say only wealthy will benefit — bizjournals.com Health Care:Health Insurance headlines
- Temperature and electron density measurements on laser driven radiative shocks — Physics of Plasmas: All Topics
- It's cuts or cuts — CEN : Letters
Latest news from MedPage Today Cardiovascular:
- AHA: Women Receive Less Cardiovascular Secondary Prevention
- AHA: Chest Protectors Have Fatal Flaws in Blocking Cardiac Arrest
- AHA: No Cardiovascular Benefit from Folic Acid and B Vitamins
- AHA: Attention from Pharmacist Improves Compliance for Older Patients
- AHA: Non-Invasive Office-Based Test Could Increase Appropriate Use of ICDs
- AHA: Human Atrial Natiuretic Peptide May Reduce Reperfusion Injury
- AHA: Blood Test Improves Management of Acute Heart Failure
- AHA: Novel Drug Effective for Hyponatremia in Heart Failure Patients